BMJ has appointed its first Entrepreneur in Residence, Lara Mott, to support its strategy of working with innovators in healthcare with the aim of creating ‘a healthier world.’
The appointment is part of the BMJ New Ventures programme, which was set up in 2016 to work with entrepreneurs in young companies who share its vision for a healthier world, and who can benefit from the company’s medical expertise, communications, and distribution channels.
Lara co-founded ImproveWell in 2016 to enable frontline healthcare professionals to drive change. ImproveWell is a digital solution enterprise, with a focus on quality improvement.
In less than three years, its technology has been adopted across the NHS and in the USA.
Before setting up ImproveWell, Lara worked in various senior roles across healthcare specialist investment, biotech, life sciences consulting and financial services businesses.
In 2014 she supported one of the largest UK biotech fundraisings at flotation on the London Stock Exchange, raising £200 million for Circassia, a specialty pharmaceutical company. And in 2016 she directed a €660 million healthcare private equity fundraise for GHO Capital.
She was deputy chair of the UK BioIndustry Association’s Communications Advisory Committee for over four years, and was also a trustee for the award winning international NGO, Selfless, from 2015 to 2016.
As BMJ’s first Entrepreneur in Residence, Lara will be supporting BMJ’s strategy team to widen its horizons for innovation and entrepreneurship. As well as sharing her experience of innovation, Lara will provide strategic advice for internal and external projects. She will also help BMJ to shape the future of its Entrepreneur in Residence programme.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
